In this study, we observed that GPS could be used as an immuno-enhancer to significantly improve the levels of anti-RBD-specific IgA and IgG, not only in the serums but also in the lungs, which could contribute to reducing the probability of severe respiratory disease. This evidence concerns the gene CD79A and respiratory system disorder.